Search Results | Clinical Cancer Research | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L)

Clin Cancer Res 893–902.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3194

Published: 01 March 2022

View article

Includes: Supplementary data

Journal Articles

Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity

Tokiyoshi Tanegashima, Yosuke Togashi, Koichi Azuma, Akihiko Kawahara, Ko Ideguchi, Daisuke Sugiyama, Fumio Kinoshita, Jun Akiba, Eiji Kashiwagi, Ario Takeuchi, Takuma Irie, Katsunori Tatsugami, Tomoaki Hoshino, Masatoshi Eto, Hiroyoshi Nishikawa

Clin Cancer Res (2019) 25 (15): 4808–4819.

DOI: https://doi.org/10.1158/1078-0432.CCR-18-3991

Published: 01 August 2019

View article

Includes: Supplementary data

Journal Articles

Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer

Keiichi Ota, Koichi Azuma, Akihiko Kawahara, Satoshi Hattori, Eiji Iwama, Junko Tanizaki, Taishi Harada, Koichiro Matsumoto, Koichi Takayama, Shinzo Takamori, Masayoshi Kage, Tomoaki Hoshino, Yoichi Nakanishi, Isamu Okamoto

Clin Cancer Res (2015) 21 (17): 4014–4021.

DOI: https://doi.org/10.1158/1078-0432.CCR-15-0016

Published: 31 August 2015

View article

Includes: Supplementary data

Journal Articles

Molecular Diagnosis of Activating EGFR Mutations in Non–Small Cell Lung Cancer Using Mutation-Specific Antibodies for Immunohistochemical Analysis

Akihiko Kawahara, Chizuko Yamamoto, Kazutaka Nakashima, Koichi Azuma, Satoshi Hattori, Masaki Kashihara, Hisamichi Aizawa, Yuji Basaki, Michihiko Kuwano, Masayoshi Kage, Tetsuya Mitsudomi, Mayumi Ono

Clin Cancer Res (2010) 16 (12): 3163–3170.

DOI: https://doi.org/10.1158/1078-0432.CCR-09-3239

Published: 14 June 2010

View article

Journal Articles

Ran , a Small GTPase Gene, Encodes Cytotoxic T Lymphocyte (CTL) Epitopes Capable of Inducing HLA-A33–restricted and Tumor-Reactive CTLs in Cancer Patients

Koichi Azuma, Tetsuro Sasada, Hiroko Takedatsu, Hiroki Shomura, Makoto Koga, Yoshiaki Maeda, Akihisa Yao, Tatsuya Hirai, Arimichi Takabayashi, Shigeki Shichijo, Kyogo Itoh

Clin Cancer Res (2004) 10 (19): 6695–6702.

DOI: https://doi.org/10.1158/1078-0432.CCR-04-0818

Published: 08 October 2004

View article

NARROW

A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L)

Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity

Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer

Molecular Diagnosis of Activating EGFR Mutations in Non–Small Cell Lung Cancer Using Mutation-Specific Antibodies for Immunohistochemical Analysis

Ran , a Small GTPase Gene, Encodes Cytotoxic T Lymphocyte (CTL) Epitopes Capable of Inducing HLA-A33–restricted and Tumor-Reactive CTLs in Cancer Patients

Email alerts

AACR Journals

A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L)

Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity

Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer

Molecular Diagnosis of Activating EGFR Mutations in Non–Small Cell Lung Cancer Using Mutation-Specific Antibodies for Immunohistochemical Analysis

Ran , a Small GTPase Gene, Encodes Cytotoxic T Lymphocyte (CTL) Epitopes Capable of Inducing HLA-A33–restricted and Tumor-Reactive CTLs in Cancer Patients

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only